Heritage Wealth Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Heritage Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.09 - $37.88 $216,510 - $263,796	6,964 Added 128.63%	12,378 $441,000
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $6,448 - $7,931	224 Added 4.32%	5,414 $183,000
Q2 2022 Aug 15, 2022	BUY	$25.33 - $34.25 $16,996 - $22,981	671 Added 14.85%	5,190 $150,000
Q1 2022 Aug 15, 2022	BUY	$28.51 - $32.9 $64,061 - $73,926	2,247 Added 98.9%	4,519 $146,000
Q3 2021 Nov 10, 2021	BUY	$23.54 - $31.39 $14,500 - $19,336	616 Added 37.2%	2,272 $61,000
Q2 2021 Aug 11, 2021	BUY	$26.72 - $33.19 $17,501 - $21,739	655 Added 65.43%	1,656 $51,000
Q1 2021 Jul 16, 2021	BUY	$24.15 - $31.45 $24,174 - $31,481	1,001 New	1,001 $26,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Heritage Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Heritage Wealth Management, LLC with notifications on news.